Histopathologic changes of the ear in canine models of mucopolysaccharidosis types I and VII

Veterinary Pathology

Volumn 48, Issue 3, 2011, Pages 616-626

  Hordeaux, J ^a,b   Deniaud, J ^a   Bemelmans, I ^b   Bertrand, L ^a,b   Moreau, S ^a,b   Amiaud, J ^a   Wyers, M ^a,b   Cherel, Y ^a,b   Colle, M A ^a,b  

^a INRA UMR 703   (France)

^b LUNAM UNIVERSITÉ   (France)

Author keywords

dog; ear; lysosomal storage disease; mucopolysaccharidosis I; mucopolysaccharidosis VII; pathology; special senses

Indexed keywords

ANIMAL; ANIMAL DISEASE; ARTICLE; DOG; DOG DISEASE; EAR DISEASE; HUMAN; HURLER SYNDROME; INNER EAR; MALE; MIDDLE EAR; MUCOPOLYSACCHARIDOSIS TYPE 7; PATHOLOGY;

ANIMALS; DOG DISEASES; DOGS; EAR DISEASES; EAR, INNER; EAR, MIDDLE; HUMANS; MALE; MUCOPOLYSACCHARIDOSIS I; MUCOPOLYSACCHARIDOSIS VII;

CANIS FAMILIARIS;

EID: 79955831137     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1177/0300985810384413     Document Type: Article

References (30)

1. Baehner F,Schmiedeskamp C,Krummenauer F,Miebach E,Bajbouj M,Whybra C,Kohlschutter A,Kampmann C,Beck M. Cumulative incidence rates of the mucopolysaccharidoses in GermanyJ Inherit Metab Dis. 2005;28: 1011-1017.
2. Berry CL,Vogler C,Galvin NJ,Birkenmeier EH,Sly WS. Pathology of the ear in murine mucopolysaccharidosis type VII: morphologic correlates of hearing lossLab Invest. 1994;71: 438-445.
3. Haskins ME. Animal models for mucopolysaccharidosis disorders and their clinical relevanceActa Paediatr Suppl. 2007;96: 56-62.
4. Haskins ME,Aguirre GD,Jezyk PF,Schuchman EH,Desnick RJ,Patterson DF. Mucopolysaccharidosis type VII (Sly syndrome): beta-glucuronidase-deficient mucopolysaccharidosis in the dogAm J Pathol. 1991;138: 1553-1555.
5. Haskins ME,Desnick RJ,DiFerrante N,Jezyk PF,Patterson DF. Beta-glucuronidase deficiency in a dog: a model of human mucopolysaccharidosis VIIPediatr Res. 1984;18: 980-984.
6. Kelemen G. Hurler's syndrome and the hearing organJ Laryngol Otol. 1966;80: 791-803.
7. Komura Y,Kaga K,Ogawa Y,Yamaguchi Y,Tsuzuku T,Suzuki JI. ABR and temporal bone pathology in Hurler's diseaseInt J Pediatr Otorhinolaryngol. 1998;43: 179-188.
8. Lim DJ,Robinson M,Saunders WH. Morphologic and immunohistochemical observation of otosclerotic stapes: a preliminary studyAm J Otolaryngol. 1987;8: 282-295.
9. Lin HY,Lin SP,Chuang CK,Niu DM,Chen MR,Tsai FJ,Chao MC,Chiu PC,Lin SJ,Tsai LP,Hwu WL,Lin JL. Incidence of the mucopolysaccharidoses in Taiwan, 1984-2004Am J Med Genet A. 2009;149: 960-964.
10. Malm G,Lund AM,Mansson JE,Heiberg A. Mucopolysaccharidoses in the Scandinavian countries: incidence and prevalenceActa Paediatr. 2008;97: 1577-1581.
11. Meikle PJ,Hopwood JJ,Clague AE,Carey WF. Prevalence of lysosomal storage disordersJAMA. 1999;281: 249-254.
12. Metcalf JA,Zhang Y,Hilton MJ,Long F,Ponder KP. Mechanism of shortened bones in mucopolysaccharidosis VIIMol Genet Metab. 2009;97: 202-211.
13. Milev P,Monnerie H,Popp S,Margolis RK,Margolis RU. The core protein of the chondroitin sulfate proteoglycan phosphacan is a high-affinity ligand of fibroblast growth factor-2 and potentiates its mitogenic activityJ Biol Chem. 1998;273: 21439-21442.
14. Motamed M,Thorne S,Narula A. Treatment of otitis media with effusion in children with mucopolysaccharidosesInt J Pediatr Otorhinolaryngol. 2000;53: 121-124.
15. Murphy AM,Lambert D,Treacy EP,O'Meara A,Lynch SA. Incidence and prevalence of mucopolysaccharidosis type 1 in the Irish republicArch Dis Child. 2009;94: 52-54.
16. Nelson J. Incidence of the mucopolysaccharidoses in Northern IrelandHum Genet. 1997;101: 355-358.
17. Neufeld EF,Muenzer J The Metabolic and Molecular Basis of Inherited Disease. Scriver CR Beaudet AL Sly WS Valle D, ed. New York, NY: McGraw-Hill; 2001:3421-3452.
18. Ohlemiller KK,Hennig AK,Lett JM,Heidbreder AF,Sands MS. Inner ear pathology in the mucopolysaccharidosis VII mouseHear Res. 2002;169: 69-84.
19. Rapraeger AC,Krufka A,Olwin BB. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiationScience. 1991;252: 1705-1708.
20. Ribari O,Pereplica M,Sziklai I. Oversulfated mucopolysaccharides in the otosclerotic boneActa Otolaryngol. 1991;111: 362-365.
21. Schachern PA,Cureoglu S,Tsuprun V,Paparella MM,Whitley CB. Age-related functional and histopathological changes of the ear in the MPS I mouseInt J Pediatr Otorhinolaryngol. 2007;71: 197-203.
22. Schachern PA,Shea DA,Paparella MM. Mucopolysaccharidosis I-H (Hurler's syndrome) and human temporal bone histopathologyAnn Otol Rhinol Laryngol. 1984;93: 65-69.
23. Shull RM,Helman RG,Spellacy E,Constantopoulos G,Munger RJ,Neufeld EF. Morphologic and biochemical studies of canine mucopolysaccharidosis IAm J Pathol. 1984;114: 487-495.
24. Shull RM,Munger RJ,Spellacy E,Hall CW,Constantopoulos G,Neufeld EF. Canine alpha-l-iduronidase deficiency: a model of mucopolysaccharidosis IAm J Pathol. 1982;109: 244-248.
25. Simmons MA,Bruce IA,Penney S,Wraith E,Rothera MP. Otorhinolaryngological manifestations of the mucopolysaccharidosesInt J Pediatr Otorhinolaryngol. 2005;69: 589-595.
26. Sly WS,Brot FE,Glaser J,Stahl PD,Quinton BA,Rimoin DL,McAlister WH. Beta-glucuronidase deficiency mucopolysaccharidosisBirth Defects Orig Artic Ser. 1974;10: 239-245.
27. Sly WS,Quinton BA,McAlister WH,Rimoin DL. Beta glucuronidase deficiency: report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosisJ Pediatr. 1973;82: 249-257.
28. Suzuki K,Suzuki K Greenfield's Neuropathology. 7th ed. Graham DI Lantos PL, ed. London, UK: Arnold; 2002:653-735.
29. Sziklai I,Batta TJ,Karosi T. Otosclerosis: an organ-specific inflammatory disease with sensorineural hearing lossEur Arch Otorhinolaryngol. 2009;266: 1711-1718.
30. Wold SM,Derkay CS,Darrow DH,Proud V. Role of the pediatric otolaryngologist in diagnosis and management of children with mucopolysaccharidoses [published online ahead of print November 20, 2009]Int J Pediatr Otorhinolaryngol.: